Related Experiment Video
Updated: Jun 4, 2026

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
microRNAs in stroke pathogenesis.
1The Stroke Program, Departments of Biochemistry and Pharmacology, National University Health System, National University of Singapore, 8 Medical Drive, Singapore 117597.
microRNAs offer new insights into stroke mechanisms and treatment. These small molecules show potential as diagnostic and therapeutic tools for stroke, a leading cause of death and disability.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Stroke is a major global cause of death and disability.
- Current treatments like rtPA have limited time windows.
- Molecular mechanisms of stroke pathogenesis are not fully understood.
Purpose of the Study:
- To explore the role of microRNAs in stroke pathogenesis.
- To discuss microRNAs as potential biomarkers and therapeutic targets for stroke.
Main Methods:
- Review of current literature on microRNAs and stroke.
- Analysis of microRNA involvement in key stroke processes.
Main Results:
- MicroRNAs are key regulators of gene function with potential in stroke research.
- Specific microRNAs and their targets are implicated in endothelial dysfunction, neurovascular integrity, edema, apoptosis, inflammation, and extracellular matrix remodeling.
- MicroRNA expression reflects individual responses to stroke therapies.
Conclusions:
- MicroRNAs are crucial in understanding stroke pathogenesis.
- MicroRNAs hold promise as diagnostic and prognostic biomarkers for stroke.
- MicroRNAs represent potential novel therapeutic targets for stroke treatment.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Stroke: Introduction and Types